| Literature DB >> 35845372 |
Coraline Bichet1,2,3, Corinne Régis3, Emmanuelle Gilot-Fromont3,4, Aurélie Cohas3,5.
Abstract
Recent findings suggest that immune functions do not unidirectionally deteriorate with age but that a potentially adaptive remodeling, where functions of the immune system get downregulated while others get upregulated with age could also occur. Scarce in wild populations, longitudinal studies are yet necessary to properly understand the patterns and consequences of age variations of the immune system in the wild. Meanwhile, it is challenging to understand if the observed variations in immune parameters with age are due to changes at the within-individual level or to selective (dis)appearance of individuals with peculiar immune phenotypes. Thanks to a long-term and longitudinal monitoring of a wild Alpine marmot population, we aimed to understand within- and between-individual variation in the immune phenotype with age, in order to improve our knowledge about the occurrence and the evolutionary consequences of such age variations in the wild. To do so, we recorded the age-specific leukocyte concentration and leukocyte profile in repeatedly sampled dominant individuals. We then tested whether the potential changes with age were attributable to within-individual variations and/or selective (dis)appearance. Finally, we investigated if the leukocyte concentration and profiles were correlated to the probability of death at a given age. The leukocyte concentration was stable with age, but the relative number of lymphocytes decreased, while the relative number of neutrophils increased, over the course of an individual's life. Moreover, between individuals of the same age, individuals with fewer lymphocytes but more neutrophils were more likely to die. Therefore, selective disappearance seems to play a role in the age variations of the immune parameters in this population. Further investigations linking age variations in immune phenotype to individual fitness are needed to understand whether remodeling of the immune system with age could or could not be adaptive.Entities:
Keywords: Marmota marmota; aging; immune cells; immune remodeling; immunosenescence; mammal; survival
Year: 2022 PMID: 35845372 PMCID: PMC9273568 DOI: 10.1002/ece3.9094
Source DB: PubMed Journal: Ecol Evol ISSN: 2045-7758 Impact factor: 3.167
Parameter estimates and credible intervals at 95% (CI) for the selected models testing whether variation in leukocyte concentration or relative number of each type of leukocytes was explained by age, age at access to dominance (AAD, i.e., selective appearance), and age at last observation (ALO, i.e., selective disappearance). Parameters were obtained from the minimal adequate models. Significant effects (CI which do not overlap zero) are in bold. “—” means a parameter not retained in the model
| Dependent variable | Leukocyte concentration | Number of lymphocytes | Number of neutrophils | Number of monocytes | Number of eosinophils | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed effects | Estimate | 95% CI | Estimate | 95% CI | Estimate | 95% CI | Estimate | 95% CI | Estimate | 95% CI |
| Intercept | 16.7 | 16.47, 16.92 | 3.51 | 3.35, 3.67 | 4.03 | 3.94, 4.13 | 1.34 | 1.08, 1.60 | 0.76 | 0.43, 1.09 |
| Age | 0.09 | −0.11, 0.30 | −0.28 | −0.39, −0.17 | 0.14 | 0.08, 0.20 | −0.32 | −0.49, −0.14 | −0.01 | −0.22, 0.19 |
| AAD | −0.12 | −0.25, 0.00 | −0.01 | −0.11, 0.10 | 0.02 | −0.03, 0.07 | 0.04 | −0.10, 0.19 | −0.06 | −0.22, 0.11 |
| ALO | −0.09 | −0.28, 0.09 |
|
|
|
| 0.16 | −0.01, 0.33 | 0.13 | −0.08, 0.35 |
| Sex (male) | −0.09 | −0.29, 0.12 |
|
|
|
| 0.04 | −0.19, 0.28 | −0.06 | −0.35, 0.23 |
| Body mass | −0.05 | −0.17, 0.07 |
|
|
|
|
|
|
|
|
| Date | 0.06 | −0.08, 0.20 |
|
|
|
| 0.07 | −0.07, 0.21 | 0.05 | −0.09, 0.18 |
| Year (2012) | −0.03 | −016, 0.10 | 0.01 | −0.09, 0.10 | 0.17 | −0.12, 0.45 |
|
| ||
| Year (2013) |
|
| −0.08 | −0.20, 0.04 | −0.34 | −0.75, 0.07 | −0.2 | −0.67, 0.26 | ||
| Year (2014) |
|
| 0.09 | −0.08, 0.27 | 0 | −0.11, 0.11 | −0.2 | −0.52, 0.12 | 0.07 | −0.32, 0.46 |
| Year (2015) | 0.14 | −0.14, 0.43 | 0.08 | −0.14, 0.30 | 0 | −0.13, 0.13 | −0.2 | −0.57, 0.17 | 0.38 | −0.07, 0.82 |
| Date: year 2012 |
|
|
|
| 0.11 | −0.11, 0.33 | — | — | ||
| Date: year 2013 |
|
|
|
|
|
| — | — | ||
| Date: year 2014 | — | — | −0.13 | −0.26, −0.00 | 0.07 | −0.02, 0.17 | −0.1 | −0.43, 0.23 | — | — |
| Date: year 2015 | — | — | −0.1 | −0.22, 0.02 | 0.07 | −0.02, 0.15 | −0.24 | −0.62, 0.15 | — | — |
| Random ID (variance) | 0.02 | 0.01, 0.03 |
|
|
|
|
|
|
|
|
Between 2013 and 2015, the leukocyte concentration was determined for 79 samples from 34 individuals sampled between two and three times. Twenty‐three individuals had two samples in different years and 11 individuals had three.
Between 2011 and 2015, the leukocyte counts were determined for 169 blood smears from 52 individuals sampled between two and five times. Eighteen individuals had two samples in different years, 12 had three, 13 had four, and 9 individuals had five. Thirty‐three individuals were both measured for leukocyte concentration and leukocyte counts (which corresponds to 75 measurements).
Parameter estimates and credible intervals at 95% (CI) for the selected models testing whether within‐individual variation in leukocyte concentration or relative number of each type of leukocytes was explained by age. Parameters were obtained from the minimal adequate models. Significant effects (CI which do not overlap zero) are in bold. “—” means a parameter not retained in the model
| Dependent variable | Leukocyte concentration | Number of lymphocytes | Number of neutrophils | Number of monocytes | Number of eosinophils | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed effects | Estimate | 95% CI | Estimate | 95% CI | Estimate | 95% CI | Estimate | 95% CI | Estimate | 95% CI |
| Intercept |
|
|
|
|
|
|
|
|
|
|
| Average age | −0.06 | −0.16, 0.05 | −0.01 | −0.10, 0.08 | 0.01 | −0.04, 0.06 | −0.1 | −0.21, 0.02 | 0.09 | −0.05, 0.23 |
| Delta age | −0.11 | −0.31, 0.09 |
|
|
|
| −0.17 | −0.35, 0.01 | 0.26 | −0.62, 0.67 |
| Quadratic delta age | — | — |
|
|
|
| — | — |
|
|
| Sex (male) | −0.09 | −0.30, 0.13 |
|
| 0.07 | −0.03, 0.17 | 0.08 | −0.15, 0.31 | 0.01 | −0.28, 0.30 |
| Body mass | −0.05 | −0.17, 0.08 |
|
|
|
|
|
|
|
|
| Date | 0.06 | −0.08, 0.20 |
|
| −0.01 | −0.04, 0.03 | 0.08 | −0.06, 0.23 | 0.07 | −0.07, 0.21 |
| Year (2012) | 0.09 | −0.07, 0.26 | −0.08 | −0.19, 0.03 | 0.16 | −0.16, 0.48 |
|
| ||
| Year (2013) |
|
|
|
| −0.34 | −0.83, 0.14 | −0.11 | −0.67, 0.45 | ||
| Year (2014) |
|
| 0.32 | −0.03, 0.66 | −0.16 | −0.34, 0.02 | −0.09 | −0.63, 0.32 | 0.25 | −0.34, 0.83 |
| Year (2015) | 0.49 | −0.06, 1.04 | 0.35 | −0.11, 0.80 | −0.19 | −0.34, 0.02 | −0.23 | −0.75, 0.47 | 0.62 | −0.12, 1.36 |
| Date: year 2012 |
|
| — | — | 0.11 | −0.11, 0.33 | — | — | ||
| Date: year 2013 |
|
| — | — |
|
| — | — | ||
| Date: year 2014 | — | — | −0.07 | −0.20, −0.06 | — | — | −0.09 | −0.42, 0.23 | — | — |
| Date: year 2015 | — | — | −0.07 | −0.19, 0.06 | — | — | −0.23 | −0.61, 0.15 | — | — |
| Random ID (variance) |
|
|
|
|
|
|
|
|
|
|
Between 2013 and 2015, the leukocyte concentration was determined for 79 samples from 34 individuals sampled between two and three times. Twenty‐three individuals had two samples in different years and 11 individuals had three.
Between 2011 and 2015, the leukocyte counts were determined for 169 blood smears from 52 individuals sampled between two and five times. Eighteen individuals had two samples in different years, 12 had three, 13 had four, and 9 individuals had five. Thirty‐three individuals were both measured for leukocyte concentration and leukocyte counts (which corresponds to 75 measurements).
FIGURE 1Within‐individual age variations (delta age) of (a) leukocyte concentration and profiles for (b) the relative number of lymphocytes, (c) neutrophils, (d) monocytes, and (e) eosinophils. Dots represent the raw data with size proportional to the sample size. Black solid lines represent model predictions with their 95% prediction interval (gray areas). Model predictions and their intervals were obtained over all samples for (a) and by fixing the continuous variables to their mean over all samples and the sex to female, the year to 2013, and the individual random effect to a given individual for (b–e). The delta age effect was significant for (b) the relative number of lymphocytes, (c) neutrophils, and (e) eosinophils
Associations between immune phenotype and the mortality risk. Significant effects are in bold
| Time‐dependent covariate | Leukocyte concentration ( | Number of lymphocytes ( | Number of neutrophils ( | Number of monocytes ( | Number of eosinophils ( | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard ratio ± |
|
| Hazard ratio ± |
|
| Hazard ratio ± |
|
| Hazard ratio ± |
|
| Hazard ratio ± |
|
| |
| Leukocyte variable |
|
|
|
|
|
|
|
|
| 0.93 ± 0.07 | −1.02 | .310 | 1.04 ± 0.07 | 0.57 | .570 |
| Age at first capture |
|
|
| 1.11 ± 0.09 | 1.21 | .230 | 1.12 ± 0.09 | 1.30 | .190 | 1.07 ± 0.09 | 0.78 | .440 | 1.09 ± 0.09 | 0.89 | .370 |
| Sex (male) | 0.98 ± 0.40 | −0.04 | .970 | −0.53 ± 0.33 | −1.90 | .058 | 0.61 ± 0.33 | −1.54 | .120 | 0.72 ± 0.32 | −1.02 | .310 | 0.69 ± 0.32 | −1.18 | .240 |